# Miami International

Type: Company (MIAX)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/miami-international
Canonical HTML page: https://getbiobrief.com/entity/miami-international

## Recent coverage (1 stories)

### Urogen's ZUSDURI Revenue Soars 73% to $50.4M, Expanding Prescriber Base
2026-08-08 22:30:23 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Urogen Pharma’s bladder cancer therapy ZUSDURI generated $50.4M in Q2 net product revenue, a 73% sequential jump, as the company activated 1,444 accounts and doubled repeat prescribers. The strong commercial launch highlights robust demand in biotech’s niche oncology space.
Full story: https://getbiobrief.com/story/urogen-pharma-zusduri-revenue-surge-q2-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.